nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetazolamide—CYP3A4—type 2 diabetes mellitus	0.176	1	CbGaD
Acetazolamide—SLC22A6—Chlorpropamide—type 2 diabetes mellitus	0.0637	0.158	CbGbCtD
Acetazolamide—SLC22A6—Tolbutamide—type 2 diabetes mellitus	0.0567	0.14	CbGbCtD
Acetazolamide—SLC22A6—Nateglinide—type 2 diabetes mellitus	0.0482	0.119	CbGbCtD
Acetazolamide—SLC22A6—Glyburide—type 2 diabetes mellitus	0.0326	0.0806	CbGbCtD
Acetazolamide—SLC22A6—Losartan—type 2 diabetes mellitus	0.0298	0.0738	CbGbCtD
Acetazolamide—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0264	0.0653	CbGbCtD
Acetazolamide—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0235	0.0582	CbGbCtD
Acetazolamide—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0215	0.0532	CbGbCtD
Acetazolamide—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0188	0.0465	CbGbCtD
Acetazolamide—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.017	0.0421	CbGbCtD
Acetazolamide—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0129	0.0319	CbGbCtD
Acetazolamide—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0123	0.0306	CbGbCtD
Acetazolamide—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0123	0.0306	CbGbCtD
Acetazolamide—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0117	0.0289	CbGbCtD
Acetazolamide—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0087	0.0215	CbGbCtD
Acetazolamide—CYP3A4—Losartan—type 2 diabetes mellitus	0.00796	0.0197	CbGbCtD
Acetazolamide—AQP1—endothelium—type 2 diabetes mellitus	0.00504	0.087	CbGeAlD
Acetazolamide—AQP1—islet of Langerhans—type 2 diabetes mellitus	0.00287	0.0495	CbGeAlD
Acetazolamide—AQP1—retina—type 2 diabetes mellitus	0.00245	0.0423	CbGeAlD
Acetazolamide—CA1—nerve—type 2 diabetes mellitus	0.00243	0.042	CbGeAlD
Acetazolamide—AQP1—nephron tubule—type 2 diabetes mellitus	0.00231	0.0398	CbGeAlD
Acetazolamide—AQP1—cardiovascular system—type 2 diabetes mellitus	0.00207	0.0358	CbGeAlD
Acetazolamide—AQP1—kidney—type 2 diabetes mellitus	0.00203	0.035	CbGeAlD
Acetazolamide—AQP1—pancreas—type 2 diabetes mellitus	0.00202	0.0348	CbGeAlD
Acetazolamide—CA9—islet of Langerhans—type 2 diabetes mellitus	0.00201	0.0347	CbGeAlD
Acetazolamide—AQP1—cortex of kidney—type 2 diabetes mellitus	0.00198	0.0341	CbGeAlD
Acetazolamide—Methazolamide—CYP2E1—type 2 diabetes mellitus	0.00196	0.614	CrCbGaD
Acetazolamide—CA4—nerve—type 2 diabetes mellitus	0.0019	0.0329	CbGeAlD
Acetazolamide—AQP1—adipose tissue—type 2 diabetes mellitus	0.00183	0.0316	CbGeAlD
Acetazolamide—CA7—kidney—type 2 diabetes mellitus	0.00162	0.028	CbGeAlD
Acetazolamide—CA5A—liver—type 2 diabetes mellitus	0.00154	0.0266	CbGeAlD
Acetazolamide—CA3—cardiovascular system—type 2 diabetes mellitus	0.00152	0.0262	CbGeAlD
Acetazolamide—CA3—adipose tissue—type 2 diabetes mellitus	0.00134	0.0231	CbGeAlD
Acetazolamide—SLC22A6—nephron tubule—type 2 diabetes mellitus	0.00134	0.0231	CbGeAlD
Acetazolamide—AQP1—liver—type 2 diabetes mellitus	0.00128	0.0221	CbGeAlD
Acetazolamide—Methazolamide—CYP3A4—type 2 diabetes mellitus	0.00124	0.386	CrCbGaD
Acetazolamide—SLC22A6—cortex of kidney—type 2 diabetes mellitus	0.00115	0.0198	CbGeAlD
Acetazolamide—CA12—kidney—type 2 diabetes mellitus	0.00105	0.0182	CbGeAlD
Acetazolamide—CA5B—cardiovascular system—type 2 diabetes mellitus	0.000966	0.0167	CbGeAlD
Acetazolamide—CA3—liver—type 2 diabetes mellitus	0.00094	0.0162	CbGeAlD
Acetazolamide—CA5B—pancreas—type 2 diabetes mellitus	0.000939	0.0162	CbGeAlD
Acetazolamide—CA4—islet of Langerhans—type 2 diabetes mellitus	0.000922	0.0159	CbGeAlD
Acetazolamide—CA14—liver—type 2 diabetes mellitus	0.000854	0.0147	CbGeAlD
Acetazolamide—CA1—cardiovascular system—type 2 diabetes mellitus	0.000853	0.0147	CbGeAlD
Acetazolamide—CA5B—adipose tissue—type 2 diabetes mellitus	0.000852	0.0147	CbGeAlD
Acetazolamide—CA1—kidney—type 2 diabetes mellitus	0.000835	0.0144	CbGeAlD
Acetazolamide—CA1—pancreas—type 2 diabetes mellitus	0.000829	0.0143	CbGeAlD
Acetazolamide—CA2—islet of Langerhans—type 2 diabetes mellitus	0.000764	0.0132	CbGeAlD
Acetazolamide—CA1—adipose tissue—type 2 diabetes mellitus	0.000752	0.013	CbGeAlD
Acetazolamide—CA4—nephron tubule—type 2 diabetes mellitus	0.000742	0.0128	CbGeAlD
Acetazolamide—CA4—cardiovascular system—type 2 diabetes mellitus	0.000667	0.0115	CbGeAlD
Acetazolamide—CA2—retina—type 2 diabetes mellitus	0.000654	0.0113	CbGeAlD
Acetazolamide—CA4—kidney—type 2 diabetes mellitus	0.000652	0.0113	CbGeAlD
Acetazolamide—CA4—cortex of kidney—type 2 diabetes mellitus	0.000635	0.011	CbGeAlD
Acetazolamide—CA2—nephron tubule—type 2 diabetes mellitus	0.000615	0.0106	CbGeAlD
Acetazolamide—CA4—adipose tissue—type 2 diabetes mellitus	0.000588	0.0101	CbGeAlD
Acetazolamide—CA2—cardiovascular system—type 2 diabetes mellitus	0.000553	0.00954	CbGeAlD
Acetazolamide—CA2—kidney—type 2 diabetes mellitus	0.000541	0.00934	CbGeAlD
Acetazolamide—CA2—pancreas—type 2 diabetes mellitus	0.000537	0.00928	CbGeAlD
Acetazolamide—CA1—liver—type 2 diabetes mellitus	0.000528	0.00911	CbGeAlD
Acetazolamide—CA2—cortex of kidney—type 2 diabetes mellitus	0.000527	0.00909	CbGeAlD
Acetazolamide—CA2—adipose tissue—type 2 diabetes mellitus	0.000487	0.00842	CbGeAlD
Acetazolamide—CYP3A4—kidney—type 2 diabetes mellitus	0.000349	0.00602	CbGeAlD
Acetazolamide—CA2—liver—type 2 diabetes mellitus	0.000342	0.0059	CbGeAlD
Acetazolamide—Feeling abnormal—Glipizide—type 2 diabetes mellitus	0.000289	0.00122	CcSEcCtD
Acetazolamide—Dyspepsia—Glimepiride—type 2 diabetes mellitus	0.000288	0.00122	CcSEcCtD
Acetazolamide—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.000287	0.00122	CcSEcCtD
Acetazolamide—Dyspepsia—Sitagliptin—type 2 diabetes mellitus	0.000287	0.00122	CcSEcCtD
Acetazolamide—Convulsion—Glyburide—type 2 diabetes mellitus	0.000286	0.00121	CcSEcCtD
Acetazolamide—Decreased appetite—Glimepiride—type 2 diabetes mellitus	0.000284	0.00121	CcSEcCtD
Acetazolamide—Hypoaesthesia—Metformin—type 2 diabetes mellitus	0.000284	0.0012	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Irbesartan—type 2 diabetes mellitus	0.000283	0.0012	CcSEcCtD
Acetazolamide—Decreased appetite—Sitagliptin—type 2 diabetes mellitus	0.000283	0.0012	CcSEcCtD
Acetazolamide—Toxic epidermal necrolysis—Ramipril—type 2 diabetes mellitus	0.000283	0.0012	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.000282	0.0012	CcSEcCtD
Acetazolamide—Fatigue—Glimepiride—type 2 diabetes mellitus	0.000282	0.0012	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.000281	0.00119	CcSEcCtD
Acetazolamide—Fatigue—Sitagliptin—type 2 diabetes mellitus	0.000281	0.00119	CcSEcCtD
Acetazolamide—Agranulocytosis—Irbesartan—type 2 diabetes mellitus	0.00028	0.00119	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Losartan—type 2 diabetes mellitus	0.00028	0.00119	CcSEcCtD
Acetazolamide—Urticaria—Glipizide—type 2 diabetes mellitus	0.000278	0.00118	CcSEcCtD
Acetazolamide—Feeling abnormal—Pioglitazone—type 2 diabetes mellitus	0.000277	0.00117	CcSEcCtD
Acetazolamide—Ill-defined disorder—Gliclazide—type 2 diabetes mellitus	0.000275	0.00117	CcSEcCtD
Acetazolamide—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000274	0.00116	CcSEcCtD
Acetazolamide—Agitation—Gliclazide—type 2 diabetes mellitus	0.000273	0.00116	CcSEcCtD
Acetazolamide—Confusional state—Glyburide—type 2 diabetes mellitus	0.000272	0.00115	CcSEcCtD
Acetazolamide—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	0.000269	0.00114	CcSEcCtD
Acetazolamide—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000269	0.00114	CcSEcCtD
Acetazolamide—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.000269	0.00114	CcSEcCtD
Acetazolamide—Hypoaesthesia—Irbesartan—type 2 diabetes mellitus	0.000268	0.00114	CcSEcCtD
Acetazolamide—Malaise—Gliclazide—type 2 diabetes mellitus	0.000268	0.00113	CcSEcCtD
Acetazolamide—Dysgeusia—Valsartan—type 2 diabetes mellitus	0.000267	0.00113	CcSEcCtD
Acetazolamide—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.000267	0.00113	CcSEcCtD
Acetazolamide—Leukopenia—Gliclazide—type 2 diabetes mellitus	0.000266	0.00113	CcSEcCtD
Acetazolamide—Headache—Repaglinide—type 2 diabetes mellitus	0.000265	0.00113	CcSEcCtD
Acetazolamide—Shock—Glyburide—type 2 diabetes mellitus	0.000265	0.00113	CcSEcCtD
Acetazolamide—Paraesthesia—Bromocriptine—type 2 diabetes mellitus	0.000265	0.00112	CcSEcCtD
Acetazolamide—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000265	0.00112	CcSEcCtD
Acetazolamide—Flushing—Metformin—type 2 diabetes mellitus	0.000265	0.00112	CcSEcCtD
Acetazolamide—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.000264	0.00112	CcSEcCtD
Acetazolamide—Dysgeusia—Orlistat—type 2 diabetes mellitus	0.000264	0.00112	CcSEcCtD
Acetazolamide—Agranulocytosis—Losartan—type 2 diabetes mellitus	0.000263	0.00112	CcSEcCtD
Acetazolamide—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.000262	0.00111	CcSEcCtD
Acetazolamide—Urticaria—Glimepiride—type 2 diabetes mellitus	0.00026	0.0011	CcSEcCtD
Acetazolamide—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.00026	0.0011	CcSEcCtD
Acetazolamide—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000259	0.0011	CcSEcCtD
Acetazolamide—Convulsion—Gliclazide—type 2 diabetes mellitus	0.000257	0.00109	CcSEcCtD
Acetazolamide—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.000256	0.00109	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000255	0.00108	CcSEcCtD
Acetazolamide—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.000254	0.00108	CcSEcCtD
Acetazolamide—Hypoaesthesia—Losartan—type 2 diabetes mellitus	0.000252	0.00107	CcSEcCtD
Acetazolamide—Nausea—Repaglinide—type 2 diabetes mellitus	0.000252	0.00107	CcSEcCtD
Acetazolamide—Asthenia—Glipizide—type 2 diabetes mellitus	0.000251	0.00107	CcSEcCtD
Acetazolamide—Tinnitus—Irbesartan—type 2 diabetes mellitus	0.000251	0.00106	CcSEcCtD
Acetazolamide—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000251	0.00106	CcSEcCtD
Acetazolamide—Ill-defined disorder—Orlistat—type 2 diabetes mellitus	0.00025	0.00106	CcSEcCtD
Acetazolamide—Flushing—Irbesartan—type 2 diabetes mellitus	0.00025	0.00106	CcSEcCtD
Acetazolamide—Discomfort—Gliclazide—type 2 diabetes mellitus	0.00025	0.00106	CcSEcCtD
Acetazolamide—Photosensitivity reaction—Ramipril—type 2 diabetes mellitus	0.000248	0.00105	CcSEcCtD
Acetazolamide—Confusional state—Gliclazide—type 2 diabetes mellitus	0.000244	0.00104	CcSEcCtD
Acetazolamide—Dysgeusia—Metformin—type 2 diabetes mellitus	0.000243	0.00103	CcSEcCtD
Acetazolamide—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000243	0.00103	CcSEcCtD
Acetazolamide—Malaise—Orlistat—type 2 diabetes mellitus	0.000243	0.00103	CcSEcCtD
Acetazolamide—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.000242	0.00103	CcSEcCtD
Acetazolamide—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000241	0.00102	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Ramipril—type 2 diabetes mellitus	0.00024	0.00102	CcSEcCtD
Acetazolamide—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.00024	0.00102	CcSEcCtD
Acetazolamide—Erythema multiforme—Losartan—type 2 diabetes mellitus	0.000239	0.00102	CcSEcCtD
Acetazolamide—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000238	0.00101	CcSEcCtD
Acetazolamide—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000237	0.00101	CcSEcCtD
Acetazolamide—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000237	0.00101	CcSEcCtD
Acetazolamide—Tinnitus—Losartan—type 2 diabetes mellitus	0.000236	0.001	CcSEcCtD
Acetazolamide—Flushing—Losartan—type 2 diabetes mellitus	0.000235	0.000997	CcSEcCtD
Acetazolamide—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000235	0.000995	CcSEcCtD
Acetazolamide—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000234	0.000994	CcSEcCtD
Acetazolamide—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000234	0.000994	CcSEcCtD
Acetazolamide—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000234	0.000992	CcSEcCtD
Acetazolamide—Convulsion—Orlistat—type 2 diabetes mellitus	0.000233	0.00099	CcSEcCtD
Acetazolamide—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000233	0.000989	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000233	0.000987	CcSEcCtD
Acetazolamide—Dizziness—Glipizide—type 2 diabetes mellitus	0.000232	0.000983	CcSEcCtD
Acetazolamide—Ill-defined disorder—Metformin—type 2 diabetes mellitus	0.00023	0.000977	CcSEcCtD
Acetazolamide—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.00023	0.000974	CcSEcCtD
Acetazolamide—Dysgeusia—Irbesartan—type 2 diabetes mellitus	0.000229	0.000973	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Ramipril—type 2 diabetes mellitus	0.000229	0.00097	CcSEcCtD
Acetazolamide—Discomfort—Orlistat—type 2 diabetes mellitus	0.000227	0.000961	CcSEcCtD
Acetazolamide—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000226	0.000957	CcSEcCtD
Acetazolamide—Malaise—Metformin—type 2 diabetes mellitus	0.000224	0.000949	CcSEcCtD
Acetazolamide—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000224	0.000949	CcSEcCtD
Acetazolamide—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000223	0.000946	CcSEcCtD
Acetazolamide—Vomiting—Glipizide—type 2 diabetes mellitus	0.000223	0.000945	CcSEcCtD
Acetazolamide—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000222	0.000944	CcSEcCtD
Acetazolamide—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000222	0.000942	CcSEcCtD
Acetazolamide—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000222	0.000941	CcSEcCtD
Acetazolamide—CYP3A4—liver—type 2 diabetes mellitus	0.000221	0.00381	CbGeAlD
Acetazolamide—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.00022	0.000932	CcSEcCtD
Acetazolamide—Headache—Glipizide—type 2 diabetes mellitus	0.000219	0.000931	CcSEcCtD
Acetazolamide—Shock—Valsartan—type 2 diabetes mellitus	0.000219	0.000928	CcSEcCtD
Acetazolamide—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000218	0.000924	CcSEcCtD
Acetazolamide—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000217	0.000922	CcSEcCtD
Acetazolamide—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.000217	0.000922	CcSEcCtD
Acetazolamide—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000216	0.000917	CcSEcCtD
Acetazolamide—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000216	0.000916	CcSEcCtD
Acetazolamide—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000216	0.000914	CcSEcCtD
Acetazolamide—Agitation—Irbesartan—type 2 diabetes mellitus	0.000215	0.000913	CcSEcCtD
Acetazolamide—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000215	0.000913	CcSEcCtD
Acetazolamide—Urticaria—Glyburide—type 2 diabetes mellitus	0.000214	0.000909	CcSEcCtD
Acetazolamide—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000213	0.000904	CcSEcCtD
Acetazolamide—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000212	0.000898	CcSEcCtD
Acetazolamide—Malaise—Irbesartan—type 2 diabetes mellitus	0.000211	0.000896	CcSEcCtD
Acetazolamide—Headache—Pioglitazone—type 2 diabetes mellitus	0.00021	0.000892	CcSEcCtD
Acetazolamide—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.00021	0.000889	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000209	0.000887	CcSEcCtD
Acetazolamide—Discomfort—Metformin—type 2 diabetes mellitus	0.000209	0.000886	CcSEcCtD
Acetazolamide—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000209	0.000885	CcSEcCtD
Acetazolamide—Nausea—Glipizide—type 2 diabetes mellitus	0.000208	0.000883	CcSEcCtD
Acetazolamide—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000208	0.000882	CcSEcCtD
Acetazolamide—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000207	0.000879	CcSEcCtD
Acetazolamide—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000205	0.000871	CcSEcCtD
Acetazolamide—Headache—Glimepiride—type 2 diabetes mellitus	0.000205	0.000869	CcSEcCtD
Acetazolamide—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000205	0.000868	CcSEcCtD
Acetazolamide—Headache—Sitagliptin—type 2 diabetes mellitus	0.000204	0.000866	CcSEcCtD
Acetazolamide—Agitation—Losartan—type 2 diabetes mellitus	0.000203	0.000859	CcSEcCtD
Acetazolamide—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000202	0.000859	CcSEcCtD
Acetazolamide—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000202	0.000856	CcSEcCtD
Acetazolamide—Flushing—Ramipril—type 2 diabetes mellitus	0.000202	0.000855	CcSEcCtD
Acetazolamide—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.0002	0.000847	CcSEcCtD
Acetazolamide—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.0002	0.000846	CcSEcCtD
Acetazolamide—Shock—Metformin—type 2 diabetes mellitus	0.000199	0.000845	CcSEcCtD
Acetazolamide—Malaise—Losartan—type 2 diabetes mellitus	0.000199	0.000843	CcSEcCtD
Acetazolamide—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000198	0.000841	CcSEcCtD
Acetazolamide—Somnolence—Valsartan—type 2 diabetes mellitus	0.000198	0.000839	CcSEcCtD
Acetazolamide—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000197	0.000837	CcSEcCtD
Acetazolamide—Leukopenia—Losartan—type 2 diabetes mellitus	0.000197	0.000837	CcSEcCtD
Acetazolamide—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000197	0.000836	CcSEcCtD
Acetazolamide—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000196	0.000831	CcSEcCtD
Acetazolamide—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000195	0.000827	CcSEcCtD
Acetazolamide—Nausea—Glimepiride—type 2 diabetes mellitus	0.000194	0.000824	CcSEcCtD
Acetazolamide—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000194	0.000821	CcSEcCtD
Acetazolamide—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000193	0.000821	CcSEcCtD
Acetazolamide—Asthenia—Glyburide—type 2 diabetes mellitus	0.000193	0.000821	CcSEcCtD
Acetazolamide—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000193	0.00082	CcSEcCtD
Acetazolamide—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000192	0.000816	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000192	0.000815	CcSEcCtD
Acetazolamide—Fatigue—Valsartan—type 2 diabetes mellitus	0.000192	0.000813	CcSEcCtD
Acetazolamide—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000191	0.000812	CcSEcCtD
Acetazolamide—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000191	0.000811	CcSEcCtD
Acetazolamide—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000191	0.00081	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.00019	0.000805	CcSEcCtD
Acetazolamide—Fatigue—Orlistat—type 2 diabetes mellitus	0.000189	0.000804	CcSEcCtD
Acetazolamide—Shock—Irbesartan—type 2 diabetes mellitus	0.000188	0.000798	CcSEcCtD
Acetazolamide—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000188	0.000795	CcSEcCtD
Acetazolamide—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000187	0.000794	CcSEcCtD
Acetazolamide—Discomfort—Losartan—type 2 diabetes mellitus	0.000185	0.000786	CcSEcCtD
Acetazolamide—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000185	0.000785	CcSEcCtD
Acetazolamide—Headache—Bromocriptine—type 2 diabetes mellitus	0.000185	0.000784	CcSEcCtD
Acetazolamide—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000184	0.000783	CcSEcCtD
Acetazolamide—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000182	0.000772	CcSEcCtD
Acetazolamide—Confusional state—Losartan—type 2 diabetes mellitus	0.000181	0.000769	CcSEcCtD
Acetazolamide—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000181	0.000768	CcSEcCtD
Acetazolamide—Somnolence—Metformin—type 2 diabetes mellitus	0.00018	0.000764	CcSEcCtD
Acetazolamide—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.00018	0.000763	CcSEcCtD
Acetazolamide—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000178	0.000756	CcSEcCtD
Acetazolamide—Shock—Losartan—type 2 diabetes mellitus	0.000177	0.000751	CcSEcCtD
Acetazolamide—Urticaria—Valsartan—type 2 diabetes mellitus	0.000177	0.00075	CcSEcCtD
Acetazolamide—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000176	0.000747	CcSEcCtD
Acetazolamide—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000176	0.000747	CcSEcCtD
Acetazolamide—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000175	0.000744	CcSEcCtD
Acetazolamide—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000175	0.000743	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000175	0.000742	CcSEcCtD
Acetazolamide—Fatigue—Metformin—type 2 diabetes mellitus	0.000175	0.000741	CcSEcCtD
Acetazolamide—Urticaria—Orlistat—type 2 diabetes mellitus	0.000175	0.000741	CcSEcCtD
Acetazolamide—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000174	0.000737	CcSEcCtD
Acetazolamide—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000174	0.000737	CcSEcCtD
Acetazolamide—Agitation—Ramipril—type 2 diabetes mellitus	0.000174	0.000737	CcSEcCtD
Acetazolamide—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000172	0.000728	CcSEcCtD
Acetazolamide—Vomiting—Glyburide—type 2 diabetes mellitus	0.000171	0.000727	CcSEcCtD
Acetazolamide—Malaise—Ramipril—type 2 diabetes mellitus	0.00017	0.000723	CcSEcCtD
Acetazolamide—Somnolence—Irbesartan—type 2 diabetes mellitus	0.00017	0.000721	CcSEcCtD
Acetazolamide—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000169	0.000718	CcSEcCtD
Acetazolamide—Headache—Glyburide—type 2 diabetes mellitus	0.000169	0.000716	CcSEcCtD
Acetazolamide—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000168	0.000714	CcSEcCtD
Acetazolamide—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000167	0.000708	CcSEcCtD
Acetazolamide—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000166	0.000705	CcSEcCtD
Acetazolamide—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000166	0.000703	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000165	0.0007	CcSEcCtD
Acetazolamide—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000165	0.000699	CcSEcCtD
Acetazolamide—Convulsion—Ramipril—type 2 diabetes mellitus	0.000164	0.000695	CcSEcCtD
Acetazolamide—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000162	0.000685	CcSEcCtD
Acetazolamide—Urticaria—Metformin—type 2 diabetes mellitus	0.000161	0.000683	CcSEcCtD
Acetazolamide—Nausea—Glyburide—type 2 diabetes mellitus	0.00016	0.000679	CcSEcCtD
Acetazolamide—Dizziness—Gliclazide—type 2 diabetes mellitus	0.00016	0.000679	CcSEcCtD
Acetazolamide—Somnolence—Losartan—type 2 diabetes mellitus	0.00016	0.000678	CcSEcCtD
Acetazolamide—Asthenia—Valsartan—type 2 diabetes mellitus	0.00016	0.000677	CcSEcCtD
Acetazolamide—Discomfort—Ramipril—type 2 diabetes mellitus	0.000159	0.000674	CcSEcCtD
Acetazolamide—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000158	0.000672	CcSEcCtD
Acetazolamide—Asthenia—Orlistat—type 2 diabetes mellitus	0.000158	0.000669	CcSEcCtD
Acetazolamide—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000158	0.000668	CcSEcCtD
Acetazolamide—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000156	0.000663	CcSEcCtD
Acetazolamide—Confusional state—Ramipril—type 2 diabetes mellitus	0.000156	0.00066	CcSEcCtD
Acetazolamide—Fatigue—Losartan—type 2 diabetes mellitus	0.000155	0.000658	CcSEcCtD
Acetazolamide—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000154	0.000654	CcSEcCtD
Acetazolamide—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000154	0.000653	CcSEcCtD
Acetazolamide—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000152	0.000646	CcSEcCtD
Acetazolamide—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000152	0.000644	CcSEcCtD
Acetazolamide—Shock—Ramipril—type 2 diabetes mellitus	0.000152	0.000644	CcSEcCtD
Acetazolamide—Headache—Gliclazide—type 2 diabetes mellitus	0.000152	0.000643	CcSEcCtD
Acetazolamide—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000151	0.000641	CcSEcCtD
Acetazolamide—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000151	0.000641	CcSEcCtD
Acetazolamide—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.00015	0.000638	CcSEcCtD
Acetazolamide—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000148	0.000629	CcSEcCtD
Acetazolamide—Dizziness—Valsartan—type 2 diabetes mellitus	0.000147	0.000624	CcSEcCtD
Acetazolamide—Dizziness—Orlistat—type 2 diabetes mellitus	0.000145	0.000617	CcSEcCtD
Acetazolamide—Asthenia—Metformin—type 2 diabetes mellitus	0.000145	0.000616	CcSEcCtD
Acetazolamide—Nausea—Gliclazide—type 2 diabetes mellitus	0.000144	0.00061	CcSEcCtD
Acetazolamide—Urticaria—Losartan—type 2 diabetes mellitus	0.000143	0.000606	CcSEcCtD
Acetazolamide—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000142	0.000603	CcSEcCtD
Acetazolamide—Vomiting—Valsartan—type 2 diabetes mellitus	0.000141	0.0006	CcSEcCtD
Acetazolamide—Vomiting—Orlistat—type 2 diabetes mellitus	0.00014	0.000593	CcSEcCtD
Acetazolamide—Headache—Valsartan—type 2 diabetes mellitus	0.000139	0.000591	CcSEcCtD
Acetazolamide—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000139	0.000588	CcSEcCtD
Acetazolamide—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000139	0.000588	CcSEcCtD
Acetazolamide—Headache—Orlistat—type 2 diabetes mellitus	0.000138	0.000584	CcSEcCtD
Acetazolamide—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000137	0.000582	CcSEcCtD
Acetazolamide—Somnolence—Ramipril—type 2 diabetes mellitus	0.000137	0.000582	CcSEcCtD
Acetazolamide—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000136	0.000576	CcSEcCtD
Acetazolamide—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000134	0.000569	CcSEcCtD
Acetazolamide—Dizziness—Metformin—type 2 diabetes mellitus	0.000134	0.000568	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000133	0.000565	CcSEcCtD
Acetazolamide—Fatigue—Ramipril—type 2 diabetes mellitus	0.000133	0.000564	CcSEcCtD
Acetazolamide—Nausea—Valsartan—type 2 diabetes mellitus	0.000132	0.00056	CcSEcCtD
Acetazolamide—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000131	0.000555	CcSEcCtD
Acetazolamide—Nausea—Orlistat—type 2 diabetes mellitus	0.000131	0.000554	CcSEcCtD
Acetazolamide—Asthenia—Losartan—type 2 diabetes mellitus	0.000129	0.000547	CcSEcCtD
Acetazolamide—Vomiting—Metformin—type 2 diabetes mellitus	0.000129	0.000546	CcSEcCtD
Acetazolamide—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000127	0.000539	CcSEcCtD
Acetazolamide—Headache—Metformin—type 2 diabetes mellitus	0.000127	0.000538	CcSEcCtD
Acetazolamide—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000126	0.000536	CcSEcCtD
Acetazolamide—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000123	0.000522	CcSEcCtD
Acetazolamide—Urticaria—Ramipril—type 2 diabetes mellitus	0.000123	0.00052	CcSEcCtD
Acetazolamide—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000122	0.000517	CcSEcCtD
Acetazolamide—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000122	0.000516	CcSEcCtD
Acetazolamide—Nausea—Metformin—type 2 diabetes mellitus	0.00012	0.00051	CcSEcCtD
Acetazolamide—Headache—Irbesartan—type 2 diabetes mellitus	0.00012	0.000508	CcSEcCtD
Acetazolamide—Dizziness—Losartan—type 2 diabetes mellitus	0.000119	0.000505	CcSEcCtD
Acetazolamide—Vomiting—Losartan—type 2 diabetes mellitus	0.000114	0.000485	CcSEcCtD
Acetazolamide—Nausea—Irbesartan—type 2 diabetes mellitus	0.000114	0.000482	CcSEcCtD
Acetazolamide—Headache—Losartan—type 2 diabetes mellitus	0.000113	0.000478	CcSEcCtD
Acetazolamide—Asthenia—Ramipril—type 2 diabetes mellitus	0.000111	0.000469	CcSEcCtD
Acetazolamide—Nausea—Losartan—type 2 diabetes mellitus	0.000107	0.000453	CcSEcCtD
Acetazolamide—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000106	0.000448	CcSEcCtD
Acetazolamide—Dizziness—Ramipril—type 2 diabetes mellitus	0.000102	0.000433	CcSEcCtD
Acetazolamide—Vomiting—Ramipril—type 2 diabetes mellitus	9.81e-05	0.000416	CcSEcCtD
Acetazolamide—Headache—Ramipril—type 2 diabetes mellitus	9.66e-05	0.00041	CcSEcCtD
Acetazolamide—Nausea—Ramipril—type 2 diabetes mellitus	9.16e-05	0.000389	CcSEcCtD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	2.32e-05	0.000189	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—ADRA2A—type 2 diabetes mellitus	2.32e-05	0.000189	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—MTHFR—type 2 diabetes mellitus	2.31e-05	0.000188	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—APOA1—type 2 diabetes mellitus	2.3e-05	0.000187	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—APOA1—type 2 diabetes mellitus	2.3e-05	0.000187	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	2.3e-05	0.000187	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PPARA—type 2 diabetes mellitus	2.27e-05	0.000185	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—GNB3—type 2 diabetes mellitus	2.25e-05	0.000183	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.25e-05	0.000183	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—HMOX1—type 2 diabetes mellitus	2.24e-05	0.000182	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PPARG—type 2 diabetes mellitus	2.23e-05	0.000181	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—CYP2E1—type 2 diabetes mellitus	2.23e-05	0.000181	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	2.22e-05	0.000181	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—CAT—type 2 diabetes mellitus	2.21e-05	0.00018	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—CYP1A2—type 2 diabetes mellitus	2.2e-05	0.000179	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—SLC2A1—type 2 diabetes mellitus	2.2e-05	0.000179	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—AGT—type 2 diabetes mellitus	2.2e-05	0.000179	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—CYP2E1—type 2 diabetes mellitus	2.19e-05	0.000178	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—INS—type 2 diabetes mellitus	2.18e-05	0.000178	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PPARG—type 2 diabetes mellitus	2.17e-05	0.000177	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PPARG—type 2 diabetes mellitus	2.17e-05	0.000177	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—CYP1A2—type 2 diabetes mellitus	2.17e-05	0.000176	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—CALM1—type 2 diabetes mellitus	2.16e-05	0.000176	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	2.16e-05	0.000176	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—GNB3—type 2 diabetes mellitus	2.16e-05	0.000176	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.16e-05	0.000176	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—APOE—type 2 diabetes mellitus	2.15e-05	0.000175	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—IL6—type 2 diabetes mellitus	2.15e-05	0.000175	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—HMOX1—type 2 diabetes mellitus	2.15e-05	0.000175	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—CYP3A4—type 2 diabetes mellitus	2.15e-05	0.000175	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—APOB—type 2 diabetes mellitus	2.15e-05	0.000175	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—CYP1A2—type 2 diabetes mellitus	2.14e-05	0.000174	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—APOA1—type 2 diabetes mellitus	2.13e-05	0.000173	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—INS—type 2 diabetes mellitus	2.13e-05	0.000173	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—INS—type 2 diabetes mellitus	2.13e-05	0.000173	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—CAT—type 2 diabetes mellitus	2.12e-05	0.000173	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—GCG—type 2 diabetes mellitus	2.11e-05	0.000172	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—SLC2A4—type 2 diabetes mellitus	2.11e-05	0.000172	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—GSTM1—type 2 diabetes mellitus	2.09e-05	0.00017	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	2.08e-05	0.000169	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.07e-05	0.000168	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—GNB3—type 2 diabetes mellitus	2.07e-05	0.000168	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—HMOX1—type 2 diabetes mellitus	2.06e-05	0.000168	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—APOB—type 2 diabetes mellitus	2.06e-05	0.000168	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—LPL—type 2 diabetes mellitus	2.05e-05	0.000167	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—CAT—type 2 diabetes mellitus	2.03e-05	0.000165	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PPARG—type 2 diabetes mellitus	2.03e-05	0.000165	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PPARG—type 2 diabetes mellitus	2.03e-05	0.000165	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—ADCY5—type 2 diabetes mellitus	2.01e-05	0.000163	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—ALB—type 2 diabetes mellitus	2e-05	0.000163	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—GSTM1—type 2 diabetes mellitus	2e-05	0.000163	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—GPX1—type 2 diabetes mellitus	2e-05	0.000163	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—INS—type 2 diabetes mellitus	1.99e-05	0.000162	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—INS—type 2 diabetes mellitus	1.99e-05	0.000162	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—APOB—type 2 diabetes mellitus	1.97e-05	0.000161	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—LPL—type 2 diabetes mellitus	1.97e-05	0.00016	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—ALB—type 2 diabetes mellitus	1.95e-05	0.000159	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—ALB—type 2 diabetes mellitus	1.95e-05	0.000159	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—CD36—type 2 diabetes mellitus	1.95e-05	0.000159	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—ADCY5—type 2 diabetes mellitus	1.92e-05	0.000157	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.92e-05	0.000157	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—GSTM1—type 2 diabetes mellitus	1.92e-05	0.000156	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—GPX1—type 2 diabetes mellitus	1.92e-05	0.000156	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—NOS3—type 2 diabetes mellitus	1.92e-05	0.000156	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PIK3R1—type 2 diabetes mellitus	1.92e-05	0.000156	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—LPL—type 2 diabetes mellitus	1.88e-05	0.000153	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PPARG—type 2 diabetes mellitus	1.88e-05	0.000153	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.87e-05	0.000153	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—CD36—type 2 diabetes mellitus	1.87e-05	0.000152	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—NOS3—type 2 diabetes mellitus	1.87e-05	0.000152	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—NOS3—type 2 diabetes mellitus	1.87e-05	0.000152	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.87e-05	0.000152	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PIK3R1—type 2 diabetes mellitus	1.87e-05	0.000152	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—MTHFR—type 2 diabetes mellitus	1.85e-05	0.00015	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—ADCY5—type 2 diabetes mellitus	1.84e-05	0.00015	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.84e-05	0.00015	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—INS—type 2 diabetes mellitus	1.84e-05	0.00015	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—GPX1—type 2 diabetes mellitus	1.84e-05	0.00015	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—ALB—type 2 diabetes mellitus	1.82e-05	0.000148	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—ALB—type 2 diabetes mellitus	1.82e-05	0.000148	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—GNB3—type 2 diabetes mellitus	1.82e-05	0.000148	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.82e-05	0.000148	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—HMOX1—type 2 diabetes mellitus	1.81e-05	0.000147	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PPARA—type 2 diabetes mellitus	1.81e-05	0.000147	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—CD36—type 2 diabetes mellitus	1.79e-05	0.000146	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—CAT—type 2 diabetes mellitus	1.79e-05	0.000145	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—MTHFR—type 2 diabetes mellitus	1.77e-05	0.000144	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.77e-05	0.000144	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.76e-05	0.000143	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—AGT—type 2 diabetes mellitus	1.75e-05	0.000143	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PTGS2—type 2 diabetes mellitus	1.75e-05	0.000143	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PIK3R1—type 2 diabetes mellitus	1.74e-05	0.000142	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PIK3R1—type 2 diabetes mellitus	1.74e-05	0.000142	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—NOS3—type 2 diabetes mellitus	1.74e-05	0.000142	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—NOS3—type 2 diabetes mellitus	1.74e-05	0.000142	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PPARA—type 2 diabetes mellitus	1.74e-05	0.000141	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—APOB—type 2 diabetes mellitus	1.73e-05	0.000141	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—CALM1—type 2 diabetes mellitus	1.72e-05	0.00014	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—APOE—type 2 diabetes mellitus	1.72e-05	0.00014	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PTGS2—type 2 diabetes mellitus	1.71e-05	0.000139	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PTGS2—type 2 diabetes mellitus	1.71e-05	0.000139	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—APOA1—type 2 diabetes mellitus	1.7e-05	0.000138	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—MTHFR—type 2 diabetes mellitus	1.7e-05	0.000138	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—GSTM1—type 2 diabetes mellitus	1.69e-05	0.000137	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—ALB—type 2 diabetes mellitus	1.69e-05	0.000137	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—AGT—type 2 diabetes mellitus	1.68e-05	0.000137	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PPARA—type 2 diabetes mellitus	1.66e-05	0.000135	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—GSTM1—type 2 diabetes mellitus	1.66e-05	0.000135	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—LPL—type 2 diabetes mellitus	1.66e-05	0.000135	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—CALM1—type 2 diabetes mellitus	1.65e-05	0.000135	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—APOE—type 2 diabetes mellitus	1.65e-05	0.000134	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	1.64e-05	0.000133	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—APOA1—type 2 diabetes mellitus	1.63e-05	0.000133	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—ADCY5—type 2 diabetes mellitus	1.62e-05	0.000132	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—GPX1—type 2 diabetes mellitus	1.62e-05	0.000132	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—NOS3—type 2 diabetes mellitus	1.61e-05	0.000131	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PIK3R1—type 2 diabetes mellitus	1.61e-05	0.000131	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—AGT—type 2 diabetes mellitus	1.61e-05	0.000131	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PTGS2—type 2 diabetes mellitus	1.59e-05	0.00013	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PTGS2—type 2 diabetes mellitus	1.59e-05	0.00013	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—CALM1—type 2 diabetes mellitus	1.58e-05	0.000129	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—APOE—type 2 diabetes mellitus	1.58e-05	0.000129	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—AKT1—type 2 diabetes mellitus	1.58e-05	0.000128	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—CD36—type 2 diabetes mellitus	1.57e-05	0.000128	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—APOA1—type 2 diabetes mellitus	1.56e-05	0.000127	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PPP2CA—type 2 diabetes mellitus	1.55e-05	0.000126	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PPARG—type 2 diabetes mellitus	1.5e-05	0.000122	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—MTHFR—type 2 diabetes mellitus	1.49e-05	0.000121	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PTGS2—type 2 diabetes mellitus	1.48e-05	0.00012	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—INS—type 2 diabetes mellitus	1.47e-05	0.000119	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PPARA—type 2 diabetes mellitus	1.46e-05	0.000119	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PPARG—type 2 diabetes mellitus	1.43e-05	0.000117	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—AGT—type 2 diabetes mellitus	1.42e-05	0.000115	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—INS—type 2 diabetes mellitus	1.41e-05	0.000115	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—CALM1—type 2 diabetes mellitus	1.39e-05	0.000113	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.39e-05	0.000113	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—APOE—type 2 diabetes mellitus	1.39e-05	0.000113	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PPARG—type 2 diabetes mellitus	1.38e-05	0.000112	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—APOA1—type 2 diabetes mellitus	1.37e-05	0.000112	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—AKT1—type 2 diabetes mellitus	1.37e-05	0.000111	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—INS—type 2 diabetes mellitus	1.35e-05	0.00011	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—ALB—type 2 diabetes mellitus	1.35e-05	0.00011	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—ALB—type 2 diabetes mellitus	1.29e-05	0.000105	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.29e-05	0.000105	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—NOS3—type 2 diabetes mellitus	1.29e-05	0.000105	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	1.27e-05	0.000103	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—ALB—type 2 diabetes mellitus	1.24e-05	0.000101	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.23e-05	0.0001	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—NOS3—type 2 diabetes mellitus	1.23e-05	0.0001	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PPARG—type 2 diabetes mellitus	1.21e-05	9.84e-05	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—INS—type 2 diabetes mellitus	1.19e-05	9.65e-05	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.18e-05	9.63e-05	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—NOS3—type 2 diabetes mellitus	1.18e-05	9.63e-05	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PTGS2—type 2 diabetes mellitus	1.18e-05	9.58e-05	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PTGS2—type 2 diabetes mellitus	1.13e-05	9.19e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	1.11e-05	9.01e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	1.11e-05	9.01e-05	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—ALB—type 2 diabetes mellitus	1.09e-05	8.85e-05	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PTGS2—type 2 diabetes mellitus	1.08e-05	8.81e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	1.05e-05	8.54e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	1.05e-05	8.54e-05	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PIK3R1—type 2 diabetes mellitus	1.04e-05	8.47e-05	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—NOS3—type 2 diabetes mellitus	1.04e-05	8.47e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1e-05	8.15e-05	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PTGS2—type 2 diabetes mellitus	9.51e-06	7.74e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	9.24e-06	7.52e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	9.24e-06	7.52e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	8.93e-06	7.26e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	8.93e-06	7.26e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	8.93e-06	7.26e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	8.93e-06	7.26e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	8.93e-06	7.26e-05	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—AKT1—type 2 diabetes mellitus	8.8e-06	7.17e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	8.65e-06	7.04e-05	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—AKT1—type 2 diabetes mellitus	8.58e-06	6.98e-05	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—AKT1—type 2 diabetes mellitus	8.58e-06	6.98e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	8.16e-06	6.64e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	8.16e-06	6.64e-05	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—AKT1—type 2 diabetes mellitus	8.01e-06	6.52e-05	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—AKT1—type 2 diabetes mellitus	8.01e-06	6.52e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	7.96e-06	6.48e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	7.59e-06	6.18e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	7.59e-06	6.18e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	7.59e-06	6.18e-05	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—AKT1—type 2 diabetes mellitus	7.42e-06	6.04e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	7.28e-06	5.92e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	7.28e-06	5.92e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	7e-06	5.7e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	7e-06	5.7e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	6.88e-06	5.6e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	6.76e-06	5.51e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	6.76e-06	5.51e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	6.76e-06	5.51e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	6.36e-06	5.18e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	5.96e-06	4.85e-05	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—AKT1—type 2 diabetes mellitus	5.92e-06	4.82e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	5.75e-06	4.68e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	5.75e-06	4.68e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	5.75e-06	4.68e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	5.75e-06	4.68e-05	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—AKT1—type 2 diabetes mellitus	5.67e-06	4.62e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	5.51e-06	4.49e-05	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—AKT1—type 2 diabetes mellitus	5.44e-06	4.43e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	5.13e-06	4.17e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	4.79e-06	3.9e-05	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—AKT1—type 2 diabetes mellitus	4.78e-06	3.89e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	4.69e-06	3.82e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	4.69e-06	3.82e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	4.6e-06	3.74e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	4.57e-06	3.72e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	4.57e-06	3.72e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	4.57e-06	3.72e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	4.54e-06	3.7e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	4.46e-06	3.63e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	4.41e-06	3.59e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	4.1e-06	3.34e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	4.1e-06	3.34e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	4.1e-06	3.34e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	4.02e-06	3.27e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.99e-06	3.24e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.9e-06	3.18e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.75e-06	3.05e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.71e-06	3.02e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.71e-06	3.02e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	3.55e-06	2.89e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	3.55e-06	2.89e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.06e-06	2.49e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	3.06e-06	2.49e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	3.05e-06	2.48e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	3.01e-06	2.45e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.92e-06	2.38e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.84e-06	2.31e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.79e-06	2.27e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.73e-06	2.22e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.72e-06	2.21e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.65e-06	2.16e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.62e-06	2.13e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.51e-06	2.04e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.46e-06	2e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.39e-06	1.94e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.35e-06	1.91e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.34e-06	1.9e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.31e-06	1.88e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	2.04e-06	1.66e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	2e-06	1.63e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.83e-06	1.49e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.75e-06	1.43e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.75e-06	1.43e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.6e-06	1.3e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	8.05e-07	6.55e-06	CbGpPWpGaD
